Objective: delirium occurs frequently in frail patients but is easily missed. Screening with a rapid, easy-to-use and highly sensitive instrument might help improve recognition. The aim of this study was to review attention, arousal and other rapid bedside screening instruments for delirium in older patients. Methods: a literature search was performed in PubMed, PsycINFO and Embase. We scrutinized forward citations in Google Scholar, and references of included articles and prior reviews. We included studies among older patients that investigated the sensitivity and specificity of delirium screening instruments that could be administered in 3 min or less, and did not require surrogate information. We extracted study characteristics, risk of bias, sensitivity and specificity. Results: we identified 27 studies among 4,766 patients in hospitals and nursing homes. They tested many different single and several combined screening instruments. Prevalence of delirium varied between 4% and 57%. Only one study scored a low risk of bias on all domains. Sensitivity varied between 17% and 100%, and specificity between 38% and 99%. Of the 22 tests with sensitivity ≥90%, seven also had specificity ≥80% in older patients in general. These results were approximately reproduced for the Observational Scale of Level of Arousal (OSLA) and Richmond Agitation and Sedation Scale (RASS): sensitivity and specificity were >80%. Conclusion: two arousal tests-OSLA and RASS-had reproduced high sensitivity and specificity in older patients. Nurses can administer these tests during daily interaction with patients. Test accuracy studies about rapid screening tools for delirium superimposed on dementia were scarce.
Introduction
Delirium is a serious neuropsychiatric disorder with potentially severe consequences such as longer hospital stay, poor cognitive and functional recovery, increased risk of nursing home placement and death [1] . It occurs in 10-40% of older patients in hospitals and nursing homes [2, 3] . Frailty, age above 80 years and the presence of dementia increase the risk of delirium [4] .
Around one-third of delirium cases go undetected [5] . The overlap with dementia and depression might hinder recognition, as might a history of psychiatric disease [6] . Lack of trained health care professionals can also contribute to failure in identifying delirium [7] . Screening frail older persons regularly may help detect delirium more quickly and has been advised in many guidelines [8] . The goal of screening for a disease is to identify persons that are at increased risk of having that disease in a large population (triage). If screening tests are applied to detect diseases that are easily missed, as is the case with delirium, they need to be very sensitive [9] [10] [11] [12] . Usually, a screening test cannot be used to make a definitive diagnosis, because vital diagnostic information has not been collected [13] . Subsequently, screen-positive patients need to receive a diagnostic work-up to confirm the diagnosis [9, 12, 14] . Diagnostic tests need to be very specific [9] [10] [11] . Ideally, relatively untrained personnel can perform a screening test quickly, easily and as part of routine of their clinical practice.
A number of instruments have been developed to screen for delirium such as the DOSS, the CRS and the DSI (see list of abbreviations below). In addition, diagnostic tools for delirium such as the CAM and the DRS-R98 have been used to screen for delirium [15, 16] . These tests cover all diagnostic and many supporting criteria for delirium, including (surrogate) information about acute onset and fluctuation that patients with cognitive disorders cannot provide reliably. All of the above instruments require a lot of time to administer regularly. In addition, some screening tools such as the DOSS have not been validated in patients with dementia [17] . The CAM and DRS-R98 require training, expertize and experience to be administered correctly. It is likely that the lack of an easy-to-use and rapid screening tool for delirium has hampered the implementation of regular screening [18] .
In recent years, several screening tools with a test-time of 3 min or less have been developed and validated. Such instruments may allow screening of many patients in relatively little time. The aim of this study was to review the sensitivity and specificity of rapid screening instruments for delirium in older patients.
Methods

Search strategy and selection criteria
Two authors performed an independent literature search (D. W.P.Q. and H.J.L.). First, they searched PubMed, Embase and PsycINFO with the search terms 'delirium, acute confusion, encephalopathy, clouding of consciousness, toxic psychosis', 'tool, test, instrument, assessment, questionnaire, interview, diagnostic, screening'; and 'sensitivity, specificity, accuracy, validity, reliability, predictive value, likelihood-ratio' (see online Appendix A, available in Age and Ageing online). Secondly, they scrutinized references of the selected articles and four prior reviews [15, 16, 19, 20] . Thirdly, they performed a forward citation search in Google Scholar for each included article. Finally, they asked the authors of the included studies per email whether they knew unpublished studies. If title or abstract suggested that the study investigated the test accuracy of a rapid screening instrument for delirium, the full (un)published paper-if available-was obtained. Two authors assessed the papers independently (D.W.P.Q. and H.J.L.) for eligibility. The search was finalized in 12 December 2017.
Studies were selected if they met the following inclusion criteria: a bedside screening instrument for delirium was tested; administration time was <3 min as reported in the included or another article; the study reported sensitivity and specificity of a screening tool; and the study was performed in patients aged 60 years or older. Exclusion criteria were: (index) tests to diagnose delirium (CAM, DRS-R98) or delirium tremens, or to rate the severity of delirium (MDAS) or the accompanying cognitive impairment (CTD); tests based on surrogate information because it generally takes more than 3 min to reach a caregiver and administer the test, and retrieving surrogate information is often unsuccessful [21] ; tests based on symptoms elicited during history taking; tests part of establishing the reference standard diagnosis; and studies performed in patients on mechanical ventilation. No restriction was made with respect to year of publication or language.
Data-extraction
Two authors (D.W.P.Q., H.J.L. or G.A.H., H.J.L.) independently extracted the following study characteristics: setting, number of participants, prevalence of delirium and of dementia, the index test (screening instrument), the administrator and test-time of the index test, and reference standard (criteria used to diagnose delirium).
They also assessed risk of bias with the QUADAS-2 tool [22] . This tool consists of four domains: patient selection, index test, reference standard and flow and timing of the index test and reference standard. In addition, the tool requires the assessment of the applicability of the patient population, index test and target condition. Risk of bias and applicability concerns were scored as low or high, or unclear if information was missing. We modified the assessment to fit the specifics of our review (see online Appendix A, available in Age and Ageing online).
Finally, the test accuracy of the screening instruments in terms of sensitivity and specificity were extracted for all patients and patients diagnosed with dementia as well as inter-rater reliability. Sensitivity and specificity concerned patient level data (not per assessment) and current delirium (if measured during a period, we used the day with highest delirium prevalence) for the tester with the lowest level of training in psychiatric assessment (in case of multiple testers) and the cut-off with highest sensitivity (in case of multiple cut-offs). When information about study characteristics or results was missing in the publication, we requested the author to provide it. Differences in data-extraction and risk of bias assessments were resolved in consensus meetings.
Statistical analysis
We presented the reported sensitivity, specificity, and interrater reliability of the tests in all patients, and patients with dementia. We found that confidence intervals around sensitivity and specificity were missing for a number of studies. Therefore, we extracted the raw data of these studies Rapid bedside screening instruments for delirium in older patients (number of true positives, false positives, true negatives, false negatives) and calculated the 95% confidence intervals with STATA 14.0. Results were not pooled across studies.
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Results
The literature search yielded 6,077 hits. The search in the online bibliographies yielded 84 potentially eligible articles, the forward citation search 67, references of reviews and articles 101, and responses of 18 authors 13. After exclusion of duplicates we assessed 68 full-texts for eligibility. Finally, 27 studies were included that were reported in 31 publications (Figure 1 ) [9-11, 14, 23-49] . Most excluded studies did not report test accuracy of a rapid test (see online Appendix A for references, available in Age and Ageing online).
Study characteristics
The studies investigated 1-20 different single or combined tests. MOTYB was studied most often (seven studies). Table 1 presents the key characteristics of the study designs. The setting was mostly a geriatric, surgical or acute care ward, or emergency department of a hospital. One study was performed in a consultation-liaison psychiatry service, one in a hospice and four studies in a nursing home. The number of participants varied between 14 and 500. The prevalence of delirium varied between 4% and 57%. Table 2 shows the results of the risk of bias assessment. One of the 27 included studies had a low risk of bias on all items [30] . Twelve studies scored reasonably well with only one or two domains with a high or unclear risk of bias. Fourteen studies scored a high risk of bias for selection of patients due to exclusion criteria that we deemed inappropriate such as previous diagnosis of dementia [25, 34, 44] or psychiatric illness [37, 39, 44, 48] , expected hospital stay of ≤2 days [11, 24] , patients in rehabilitation, respite care [23] , ophthalmological, or gynecological wards [46] , and being too unwell or cognitively incapable to consent to participation [10, 26, 35, 45] . One study enrolled patients in office hours only [24] and another excluded patients older than 80 years [25] . In addition, almost all studies requested patients to provide informed consent before inclusion, which might have led to exclusion of relatively severe cases of delirium. Significant heterogeneity existed in the professional background of the individuals performing the index tests. Applicability concerns were low for most populations, screening tests and target conditions. Table 3 presents the sensitivity and specificity of the rapid screening instruments for delirium. Most were attention or level of arousal assessment tests. The test-time varied from 7 sec for RADAR to 3 min for combinations of tests per assessment. All tests were described as easy and requiring minimal training (up to 45 min) and minimal clinical experience. The articles described how the tests needed to be rated and which cut-offs to use (see online appendix for content of tests, available in Age and Ageing online).
Test accuracy
Twenty-six studies reported results for mixed groups of patients with and without dementia. and combinations of tests varied between 17% and 100%. Twenty-two instruments had a sensitivity of 90% or higher. Of these tests, only the RASS + Lunch BW (DTS) had a lower confidence interval limit above 90%. The specificity of the tests varied between 14% and 100%. Of the tests with sensitivity of 90% or more only the AMT-4, DCT-2, GAR, MOTYB, OSLA, RASS and 'writing name and address' had specificity of 80% or more. Sensitivity results were reproduced for AMT-4, OSLA and RASS, but sensitivity and specificity results (approximately) only for OSLA and RASS (see online Appendix A, available in Age and Ageing online).
Nine studies reported test accuracy of screening tools in patients with dementia. Sensitivity varied from 21% to 100%, and specificity from 15% to 96%. Eight tests had a sensitivity of 90% or higher, but only the OSLA + SAVEAHAART showed specificity of 80% or higher. None of the findings in patients with dementia have been reproduced consistently. In both groups 'older patients in general' and 'patients with dementia', six tests had high sensitivity of 90% or higher, but none had specificity of 80% or higher.
In general, confidence intervals around sensitivity and specificity were wide in most studies, indicating insufficiently large study populations. Most studies did not report interrater reliability, but if reported, it was generally high.
Discussion
We performed a systematic review of rapid and easy-toadminister screening instruments for delirium in older patients. The tools took 3 min or less to administer. The AMT-4, DCT-2, GAR, OSLA, RASS and 'writing name and address' had sensitivity above 90% and specificity above 80% in older patients in general. The OSLA + SAVEAHAART performed well in those with dementia.
Promising tests
Successful implementation of a screening delirium tool is affected by the administration time, the training required, the burden posed to the patient, and its appropriateness in the clinical setting it is used [12, 16, 21] . To minimize the burden of screening on professionals, patients and resources, and maximize the number of cases found, we and other authors propose a two-step approach [12, 30, 35, 47, 50] . A highly sensitive tool is needed in the first step to detect as many possible cases of delirium as possible (few false-negative cases), and a highly specific tool in the second step to make definitive diagnoses (few false-positive cases).
Most tests with sensitivity of 90% or more and specificity of 80% or more either require observation of level of arousal (GAR, RASS, OSLA), a combination of such a test with an attention test (OSLA + SAVEAHAART), or multiple cognitive tests (AMT-4, DCT-2). Sensitivity results were reproduced for AMT-4, OSLA and RASS, but specificity results only for OSLA and RASS in general older populations. Remarkably, both latter tests are level of arousal tests. The OSLA + SAVEHAART might perform well in terms of sensitivity and specificity in patients with dementia. Hence, level of arousal also seems to distinguish delirium from dementia. However, these study results have not always been reproduced and study populations were sometimes small. There was no apparent relationship of test accuracies with risk of bias, delirium criteria used, and prevalence of delirium. Naturally, reported test accuracies need to be interpreted with caution because most studies reported those that would correctly classify most patients, delirious or not. In other words, high sensitivity was not always the aim, and would have been achieved if lower specificity had been accepted. With high applicability of patient populations, index tests and target condition, indirectness is not a serious concern.
Our review complements the findings of a prior study about single-item screening questions for delirium [12] . Such questions are short too but probe (subjective) symptoms of delirium such as confusion and hallucinations with the patient, surrogate or a health professional [11, 33, 51] . Sensitivity was mostly poor, but specificity sometimes very high. Other reviews about delirium instruments did not focus on short tests and did not capture the recently published tests [7, 15, 16, 19] .
Methodological challenges
Performing a diagnostic test accuracy study in patients with delirium might be challenging. All studies required patients or their legal representatives to provide informed consent. It is likely that patients with delirium and their families will not give permission due to lack of cognitive and decisional capacity as easily as patients without delirium and their families [52] . As a result, patients with (severe) delirium may not have been represented sufficiently in the study populations. The use of exclusion criteria such as 'included only in office hours' [9] , 'an expected hospital stay of ≤2 days' [11] , 'dementia with MMSE 10 or less' [26] and 'not able to speak English' [9, 35] might have negatively influenced the number and diversity of included delirium cases too [20] . In addition, exclusion of patients with dementia might have led to overestimation of specificity, because symptoms of severe dementia overlap considerably with symptoms of delirium [26, 33, 35, 37, 43] .
All studies were performed in hospitalized patients, except four studies that tested RADAR in nursing home patients and one study in a hospice [25, 37, 39, 41, 48] . In one hospital and the nursing home studies, delirium prevalence was 4-7%, lower than estimates from prior observational studies [2] . Cases may have been missed [53] . Additional studies are needed in nursing homes and hospices. Due to the overlap between delirium and (neuropsychiatric symptoms of) dementia, diagnostic expertise is needed to ensure valid reference diagnoses.
When performing a diagnostic test study in delirium, researchers need to consider how to score untestable patients. In some studies, patients were excluded if they were considered too ill or too drowsy. Many of these patients might have had a delirium. Twelve studies reported that untestable patients were considered screenpositive [9-11, 14, 25, 27, 29, 36, 39-41, 46] . We agree with this approach. Delirium will probably be missed less often if untestable patients are scored as screen-positive.
Strengths and limitations
Strength of our study was that we performed a broad search with no restriction related to publication year or language. We used the internationally accepted QUADAS-2 tool to assess risk of bias in diagnostic test accuracy studies. There were pairs of independent data extractors and they used a consensus procedure for disagreements. Our review meets the PRISMA criteria for reporting a review.
As we chose to exclude tests based on surrogate information, some relatively quick (diagnostic) tools were excluded, such as the bCAM [50], 3D-CAM [54], Nu-DESC [55] and 4AT [56] . They seemed to perform (very) well in general older patient populations and patients with dementia. Serious games and mobile computerized tests present interesting options too [57, 58] . Another limitation of our study is that our results are not generalizable to non-older or ICU patients, because we did not include studies in such patients.
Finally, test accuracy studies do not measure outcomes of implementing screening tools. Professionals have reported that they do not always believe that screening will lead to better treatment [59] . This is conceivable in younger patients with a clear underlying disease. Delirium in frail older patients, who often have multiple modifiable predisposing and precipitating conditions, would probably remain undetected and inadequately treated if it is not diagnosed [60, 61] . A diagnosis is also important for adequate psycho-education of patients, relatives and caregivers.
Conclusion
We identified 27 studies that investigated test accuracy of rapid and easy-to-administer bedside delirium screening instruments in older patients. All except one study had at least one source of potential bias. Two tests had high sensitivity and high specificity in more than one study among older hospitalized patients: the OSLA and RASS. Tests of arousal seemed to perform well in patients with dementia too, but results need to be reproduced in larger populations and long-term care settings. The advantage of rapid and frequent screening by non-specialized personnel will be that only screen-positive patients need an extensive diagnostic work-up by a medical specialist.
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Key points
• Delirium is often missed, and screening with a rapid and easy-to-use instrument might improve recognition.
• Our review identified two arousal tests-Observational Scale of Level of Arousal (OSLA) and Richmond Agitation and Sedation Scale (RASS)-that identified most delirium cases in older patients.
• Attention and orientation tests had high sensitivity too, but were generally less specific.
• Information about rapid screening tools for delirium in patients with dementia was scarce.
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